Full Name
Ioannis Papasotiriou, MD, PhD, SCym
Job Title
Founder
Company
RGCC International GmbH
Speaker Bio
In 2004, genetics pioneer Dr. Ioannis Papasotiriou founded RGCC with a steadfast commitment to personalized cancer care. Driven by his unwavering belief in the power of a patient's genes, Dr. Papasotiriou has passionately refused to access external funding that could compromise his vision and commitment to a science-driven cancer solution.
His dedication and expertise have enabled RGCC to stand at the forefront of cancer treatment, providing hope and healing to patients and their families around the world.
“If you bring in investors, they want profitability - as quickly as possible - they don’t care about the outcome.
For us, our interest is what we could do better than the protocols available in the clinical practice, so we can create better treatments, no matter whether we use current drugs or develop new treatments.
We reinvest 85% of our income directly into further research which we wouldn’t be able to do if we brought in external investors.”
- Dr. Ioannis Papasotiriou
His dedication and expertise have enabled RGCC to stand at the forefront of cancer treatment, providing hope and healing to patients and their families around the world.
“If you bring in investors, they want profitability - as quickly as possible - they don’t care about the outcome.
For us, our interest is what we could do better than the protocols available in the clinical practice, so we can create better treatments, no matter whether we use current drugs or develop new treatments.
We reinvest 85% of our income directly into further research which we wouldn’t be able to do if we brought in external investors.”
- Dr. Ioannis Papasotiriou
Speaking At
